Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Cidara nearly doubles in value as antiviral biologic prevents flu in mid-stage trial
3 weeks ago
R&D
Acting CDER chief is leaving after almost nine years at FDA
3 weeks ago
People
FDA+
Lilly’s bimagrumab boosts weight and fat loss when added to Novo's Wegovy
3 weeks ago
R&D
Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics
3 weeks ago
Deals
Diagnostics
Updated: Compass claims Phase 3 win in depression for psilocybin drug, yet stock plummets
3 weeks ago
R&D
Updated: A puzzling update from Novo Nordisk and new data from Roche at #ADA25
3 weeks ago
R&D
FDA unveils new pilot program; Sage finds a buyer; Eli Lilly to acquire Verve; and more
3 weeks ago
Weekly
Vertex's diabetes cell therapy allows 10 patients to come off insulin
3 weeks ago
R&D
Cell/Gene Tx
CHMP recommends five new drugs, reconsiders Eli Lilly’s Kisunla
3 weeks ago
Pharma
FDA+
Inside the FDA’s ‘listening’ tour: Officials agree US lags behind China on drug development
3 weeks ago
R&D
FDA+
Pharma companies are weighing how a drug’s IP location could impact tariffs
3 weeks ago
Pharma
Manufacturing
UK's NICE says Lilly, Eisai's Alzheimer's drugs aren't worth national coverage
3 weeks ago
Pharma
Early-stage investor Syncona readjusts priorities due to bleak biotech market
3 weeks ago
Financing
Startups
FDA OKs new label expansions for Dupixent and Incyte's Monjuvi
3 weeks ago
News Briefing
Enzene, Veranova separately unveil expansions; Lotte's new ADC client
3 weeks ago
Manufacturing
Roche's venture arm chief to step down in 2026; AstraZeneca obesity leader has retired
3 weeks ago
Peer Review
FDA's top cell and gene therapy leaders exit agency in ongoing CBER changes
3 weeks ago
Cell/Gene Tx
FDA+
Grail shares jump on study results for cancer test
3 weeks ago
Pharma
Diagnostics
Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot
3 weeks ago
Pharma
FDA+
Compounders lose case over semaglutide shortage
3 weeks ago
Pharma
Health Tech
Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss
3 weeks ago
R&D
CBER head Prasad adds chief medical and scientific officer to his title
3 weeks ago
Pharma
FDA+
Q&A: New BIO chair to steer industry through ‘existential threats’ despite FDA receptivity
3 weeks ago
R&D
China
BioNTech stops making cell therapy at Maryland site after dropping germ cell tumor indication
3 weeks ago
R&D
Cell/Gene Tx
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page
